Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
DUPIXENT
Generic name / active ingredient
dupilumab
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Route documented in the linked source label
Record reviewed
2026-08-22

Copy from the pack in hand

Source-linked reading points

  • For checking, keep DUPIXENT, dupilumab, 300 mg/2 mL (150 mg/mL), NDC 0024-5914-01, two single-dose pre-filled syringes, route and target market together. Seeing only “dupilumab,” “300 mg,” or a similar carton colour does not establish that a pen device, strength, package or product in another country is the same.
  • 300 mg/2 mL is the labelled total amount and volume for this exact product, while 150 mg/mL is the concentration; neither is an instruction for how much or how often an individual should use it. Do not calculate, combine or substitute another strength or device from package numbers.
  • This label panel is for a single-dose pre-filled syringe with needle shield, not a pre-filled pen. Device operation, preparation, missed use, damage, an unusual appearance, storage or disposal questions require the current instructions for the actual product and clinician/pharmacist guidance; do not use this webpage in place of the product instructions.
  • If concerned about an allergy-like reaction, breathing difficulty, swelling of the face or throat, marked illness or another acute problem, use local emergency or medical support immediately; do not independently continue, pause or change an injectable product from general web information.

Reviewed presentation examples — compare every field

  • Dupilumab 300 mg/2 mL (150 mg/mL) per pre-filled syringe; carton of 2 single-dose pre-filled syringesNDC 0024-5914-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-22
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image